Loading...
Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer
Beck, Tim N. Korobeynikov, Vladislav A. Kudinov, Alexander E. Georgopoulos, Rachel Solanki, Nehal R. Andrews-Hoke, Magda Kistner, Timothy M. Pépin, David Donahoe, Patricia K. Nicolas, Emmanuelle
Beck, Tim N.
Korobeynikov, Vladislav A.
Kudinov, Alexander E.
Georgopoulos, Rachel
Solanki, Nehal R.
Andrews-Hoke, Magda
Kistner, Timothy M.
Pépin, David
Donahoe, Patricia K.
Nicolas, Emmanuelle
Citations
Altmetric:
Genre
Journal article
Date
2016-07-19
Advisor
Committee member
Department
Cancer and Cellular Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1016/j.celrep.2016.06.043
Abstract
Anti-Müllerian hormone (AMH) and its type II receptor AMHR2, both previously thought to primarily function in gonadal tissue, were unexpectedly identified as potent regulators of transforming growth factor (TGF-β)/bone morphogenetic protein (BMP) signaling and epithelial-mesenchymal transition (EMT) in lung cancer. AMH is a TGF-β/BMP superfamily member, and AMHR2 heterodimerizes with type I receptors (ALK2, ALK3) also used by the type II receptor for BMP (BMPR2). AMH signaling regulates expression of BMPR2, ALK2, and ALK3, supports protein kinase B-nuclear factor κB (AKT-NF-κB) and SMAD survival signaling, and influences BMP-dependent signaling in non-small cell lung cancer (NSCLC). AMH and AMHR2 are selectively expressed in epithelial versus mesenchymal cells, and loss of AMH/AMHR2 induces EMT. Independent induction of EMT reduces expression of AMH and AMHR2. Importantly, EMT associated with depletion of AMH or AMHR2 results in chemoresistance but sensitizes cells to the heat shock protein 90 (HSP90) inhibitor ganetespib. Recognition of this AMH/AMHR2 axis helps to further elucidate TGF-β/BMP resistance-associated signaling and suggests new strategies for therapeutic targeting of EMT.
Description
Citation
Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, et al. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer. Cell Rep. 2016 Jul 19;16(3):657-671. doi:10.1016/j.celrep.2016.06.043.
Citation to related work
Cell Press
Has part
Cell Reports, Vol. 16, Iss. 3
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu